Marco Carpenter (PGG graduate student in the Heller) successfully defended his dissertation and graduated. He is the first graduate student from the Heller Lab, a recipient of a 2021 CHOP Postdoctoral Fellowship, and will soon join the lab of Dr. William Peranteau as a postdoc. Congratulations Marco!
Marco Carpenter, a postdoctoral fellow who will be joining the Heller lab in June 2021, received a Postdoctoral Research Fellowship for Academic Diversity at the Children’s Hospital of Philadelphia. Welcome and congratulations!
Dr. Elizabeth Heller was recently awarded a research grant award from the SynGAP Research Fund to support her lab’s work in epigenetic regulation of SynGAP1-related intellectual disability. With the SynGAP Research Fund’s award to support a postdoctoral fellow in the lab, Dr. Heller and her team will work to uncover druggable targets that could be used to develop a treatment for this rare genetic disorder. Congratulations, Dr. Heller, and many thanks to the team at the SynGAP Research Fund!
Learn more about the SynGAP Research Fund here.
Elizabeth Heller has received U18 funding from the NIH -NIDA Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research, to study Nr4a1 as a target gene in cocaine use disorder. Congratulations!
Mike Murphy is a new PhD student (NGG program) in the Heller lab, and received an NSF Graduate Research Fellowship for research entitled “Sex-specific shifts in decision-making resulting from chronic-stress potentiated epigenetic remodeling in the striatum.” Congratulations!
Marco Carpenter, a graduate student in the Heller Lab, received the NIDA Drug Abuse Dissertation Research Award (R36) for work entitled “Nr4a1 activation suppresses Cocaine-induced behavior via epigenetic regulation of homeostatic target genes.” Congratulations!
Congratulations to Elizabeth Heller for receiving the NIDA Avenir Award (DP1DA044250), Chromatin-mediated alternative splicing in reward pathophysiology